Clal Biotechnology Industries Ltd (CBI) — Cash Flow Reinvestment Rate

Latest as of September 2020: 4.61x

Clal Biotechnology Industries Ltd (CBI) has a Cash Flow Reinvestment Rate of 4.61x as of September 2020, reinvesting ILA5.10 Million (capex ILA806.00K plus investments ILA-4.29 Million) from operating cash flow of ILA1.10 Million. Explore Clal Biotechnology Industries Ltd (CBI) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

4.61x

(Capex + Investments) / Operating CF

Total Reinvested

ILA5.10 Million

Capex + Investments

Operating Cash Flow

ILA1.10 Million

ILA

Capital Expenditures

ILA806.00K

ILA

Clal Biotechnology Industries Ltd Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Clal Biotechnology Industries Ltd across 1 annual periods. Also explore Clal Biotechnology Industries Ltd total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Clal Biotechnology Industries Ltd (2019–2019)

Year-by-year capital reinvestment analysis for Clal Biotechnology Industries Ltd. For live market cap and broader valuation context, see how much is Clal Biotechnology Industries Ltd worth.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change
2019	0.89x	ILA24.14 Million	ILA27.03 Million	ILA2.83 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow